α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease von Magenau, John M., Goldstein, Steven C., Peltier, Dan, Soiffer, Robert J., Braun, Thomas, Pawarode, Attaphol, Riwes, Mary M., Kennel, Maggi, Antin, Joseph H., Cutler, Corey S., Ho, Vincent T., Alyea, Edwin P., Parkin, Brian L., Yanik, Gregory A., Choi, Sung Won, Lewis, Eli C., Dinarello, Charles A., Koreth, John, Reddy, Pavan

Volltext

A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia von Amin, Nisar A, Seymour, Erlene, Saiya-Cork, Kamlai, Parkin, Brian, Shedden, Kerby, Malek, Sami N

Volltext

Activating STAT6 mutations in follicular lymphoma von Yildiz, Mehmet, Li, Hongxiu, Bernard, Denzil, Amin, Nisar A., Ouillette, Peter, Jones, Siân, Saiya-Cork, Kamlai, Parkin, Brian, Jacobi, Kathryn, Shedden, Kerby, Wang, Shaomeng, Chang, Alfred E., Kaminski, Mark S., Malek, Sami N.

Volltext

Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia von Parkin, Brian, Ouillette, Peter, Li, Yifeng, Keller, Jennifer, Lam, Cindy, Roulston, Diane, Li, Cheng, Shedden, Kerby, Malek, Sami N.

Volltext

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT von Choi, Sung Won, Braun, Thomas, Henig, Israel, Gatza, Erin, Magenau, John, Parkin, Brian, Pawarode, Attaphol, Riwes, Mary, Yanik, Greg, Dinarello, Charles A., Reddy, Pavan

Volltext

Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controls von Xu, Jintao, He, Bing, Carver, Kyle, Vanheyningen, Debora, Parkin, Brian, Garmire, Lana X, Olszewski, Michal A, Deng, Jane C

Volltext

Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia von Long, Jianting, Parkin, Brian, Ouillette, Peter, Bixby, Dale, Shedden, Kerby, Erba, Harry, Wang, Shaomeng, Malek, Sami N.

Volltext

Rare Variant Quantitation Using Droplet Digital PCR von Parkin, Brian

Volltext

Mutant DNA quantification by digital PCR can be confounded by heating during DNA fragmentation von Kang, Qing, Parkin, Brian, Giraldez, Maria D, Tewari, Muneesh

Volltext

76865 Clinical Outcomes of Chronic Myelomonocytic Leukemia in the VA Healthcare System von Achar, Rohan, Anwar, Talha, Parkin, Brian

Volltext

Aggressive Chronic Lymphocytic Leukemia with Elevated Genomic Complexity Is Associated with Multiple Gene Defects in the Response to DNA Double-Strand Breaks von OUILLETTE, Peter, FOSSUM, Samuel, PARKIN, Brian, LI DING, BOCKENSTEDT, Paula, AL-ZOUBI, Ammar, SHEDDEN, Kerby, MALEK, Sami N

Volltext

NF1 Inactivation in Adult Acute Myelogenous Leukemia von PARKIN, Brian, OUILLETTE, Peter, AL-ZOUBI, Ammar, TALPAZ, Moshe, KUJAWSKI, Lisa, YANG LIU, SHEDDEN, Kerby, SHAKHAN, Sajid, CHENG LI, ERBA, Harry, MALEK, Sami N, YIN WANG, YAN LIU, WRIGHT, Whitney, ROULSTON, Diane, PURKAYASTHA, Anjali, DRESSEL, Amanda, KARP, Judith, BOCKENSTEDT, Paula

Volltext

Phase II Study of Tagraxofusp in Newly Diagnosed Secondary Acute Myeloid Leukemia (S-AML) after Previous Exposure to Hypomethylating Agents (TAGALONG Study) von Green, Steven D., Parkin, Brian, Lai, Catherine, Gojo, Ivana, Foster, Matthew C., Zeidner, Joshua F.

Volltext

AML-274 TAGALONG Trial: Phase II Study of Tagraxofusp and Azacitidine With or Without Venetoclax in Newly Diagnosed Secondary AML after Previous Exposure to Hypomethylating Agents von Green, Steven, Parkin, Brian, Lai, Catherine, Gojo, Ivana, Zeidner, Joshua

Volltext

The rocky road to personalized medicine in acute myeloid leukaemia von Brinda, Bryan, Khan, Irum, Parkin, Brian, Konig, Heiko

Volltext

A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma von D'Souza, Anita, Hari, Parameswaran, Pasquini, Marcelo, Braun, Thomas, Johnson, Bryon, Lundy, Steven, Couriel, Daniel, Hamadani, Mehdi, Magenau, John, Dhakal, Binod, Shah, Nirav N., Riwes, Mary, Parkin, Brian, Reddy, Pavan, Pawarode, Attaphol

Volltext

Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse von Parkin, Brian, Londoño-Joshi, Angelina, Kang, Qing, Tewari, Muneesh, Rhim, Andrew D, Malek, Sami N

Volltext

Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin von Wang, Yin, Liu, Yan, Bailey, Christopher, Zhang, Huixia, He, Miao, Sun, Duxin, Zhang, Peng, Parkin, Brian, Baer, Maria R., Zheng, Pan, Malek, Sami N., Liu, Yang

Volltext

Abstract CT224: Phase Ib study of the safety and efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in patients with relapsed or refractory CD33+ acute myeloid leukemia: Big Ten... von Arain, Saad, Patel, Pritesh, Sweiss, Karen, Parkin, Brian, Konig, Heiko, Calip, Gregory, Yavuz, Betul Gok, Quigley, John

Volltext

Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study von Arain, Saad, Avila, Ana Maria, Christian, Sonia, Patel, Pritesh, Sweiss, Karen, Parkin, Brian, Saraf, Santosh L., Rubinstein, Paul G., Calip, Gregory S, Quigley, John G.

Volltext